Protagonist Therapeutics (PTGX) Accumulated Depreciation & Amortization (2017 - 2025)
Historic Accumulated Depreciation & Amortization for Protagonist Therapeutics (PTGX) over the last 9 years, with Q3 2025 value amounting to $7.9 million.
- Protagonist Therapeutics' Accumulated Depreciation & Amortization rose 1459.3% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year increase of 1459.3%. This contributed to the annual value of $7.0 million for FY2024, which is 1284.89% up from last year.
- Protagonist Therapeutics' Accumulated Depreciation & Amortization amounted to $7.9 million in Q3 2025, which was up 1459.3% from $7.6 million recorded in Q2 2025.
- Over the past 5 years, Protagonist Therapeutics' Accumulated Depreciation & Amortization peaked at $7.9 million during Q3 2025, and registered a low of $4.5 million during Q1 2022.
- Its 5-year average for Accumulated Depreciation & Amortization is $6.3 million, with a median of $6.4 million in 2023.
- Examining YoY changes over the last 5 years, Protagonist Therapeutics' Accumulated Depreciation & Amortization showed a top increase of 2137.02% in 2023 and a maximum decrease of 643.85% in 2023.
- Quarter analysis of 5 years shows Protagonist Therapeutics' Accumulated Depreciation & Amortization stood at $5.8 million in 2021, then increased by 15.0% to $6.7 million in 2022, then decreased by 6.44% to $6.2 million in 2023, then grew by 12.85% to $7.0 million in 2024, then increased by 12.85% to $7.9 million in 2025.
- Its last three reported values are $7.9 million in Q3 2025, $7.6 million for Q2 2025, and $7.3 million during Q1 2025.